These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38063202)

  • 21. Molecular docking and dynamics supported investigation of antiviral activity of Lichen metabolites of
    Bhat NB; Das S; Sridevi BVS; H RC; Nayaka S; S N; Birangal SR; Shenoy GG; Joseph A
    J Biomol Struct Dyn; 2023; 41(21):11484-11497. PubMed ID: 36803674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
    Schuhmacher A; Reichling J; Schnitzler P
    Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quindoline-derivatives display potent G-quadruplex-mediated antiviral activity against herpes simplex virus 1.
    Frasson I; Soldà P; Nadai M; Tassinari M; Scalabrin M; Gokhale V; Hurley LH; Richter SN
    Antiviral Res; 2022 Dec; 208():105432. PubMed ID: 36228762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proanthocyanidin-enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration.
    Gescher K; Kühn J; Lorentzen E; Hafezi W; Derksen A; Deters A; Hensel A
    J Ethnopharmacol; 2011 Mar; 134(2):468-74. PubMed ID: 21211557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand-based drug design against Herpes Simplex Virus-1 capsid protein by modification of limonene through in silico approaches.
    Islam MR; Islam Sovon MS; Amena U; Rahman M; Hosen ME; Kumer A; Bourhia M; Bin Jardan YA; Ibenmoussa S; Wondmie GF
    Sci Rep; 2024 Apr; 14(1):9828. PubMed ID: 38684729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminomethylnaphthoquinones and HSV-1: in vitro and in silico evaluations of potential antivirals.
    Pires de Mello CP; Sardoux NS; Terra L; Amorim LC; Vargas MD; da Silva GB; Castro HC; Giongo VA; Madeira LF; Paixão IC
    Antivir Ther; 2016; 21(6):507-515. PubMed ID: 26913545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic pregnenolone derivatives as antiviral agents against acyclovir-resistant isolates of Herpes Simplex Virus Type 1.
    Dávola ME; Mazaira GI; Galigniana MD; Alché LE; Ramírez JA; Barquero AA
    Antiviral Res; 2015 Oct; 122():55-63. PubMed ID: 26259812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antiviral activity of (Z)- and (E)-2,2-[bis(hydroxymethyl)cyclopropylidene]methylpurines and -pyrimidines: second-generation methylenecyclopropane analogues of nucleosides.
    Zhou S; Breitenbach JM; Borysko KZ; Drach JC; Kern ER; Gullen E; Cheng YC; Zemlicka J
    J Med Chem; 2004 Jan; 47(3):566-75. PubMed ID: 14736238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Preclinical Model for Studying Herpes Simplex Virus Infection.
    Tajpara P; Mildner M; Schmidt R; Vierhapper M; Matiasek J; Popow-Kraupp T; Schuster C; Elbe-Bürger A
    J Invest Dermatol; 2019 Mar; 139(3):673-682. PubMed ID: 30414908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics-pharmacodynamics of the helicase-primase inhibitor pritelivir following treatment of wild-type or pritelivir-resistant virus infection in a murine herpes simplex virus 1 infection model.
    Biswas S; Sukla S; Goldner T; Field HJ; Kropeit D; Paulsen D; Welbers A; Ruebsamen-Schaeff H; Zimmermann H; Birkmann A
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3843-52. PubMed ID: 24752278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.
    Yang L; Mo X; Yang H; Dai H; Tan F
    J Mol Model; 2014 Jul; 20(7):2321. PubMed ID: 24961898
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic derivatives of the antifungal drug ciclopirox are active against herpes simplex virus 2.
    Zangi M; Donald KA; Casals AG; Franson AD; Yu AJ; Marker EM; Woodson ME; Campbell SD; Mottaleb MA; Narayana Hajay Kumar TV; Reddy MS; Raghava Reddy LV; Sadhukhan SK; Griggs DW; Morrison LA; Meyers MJ
    Eur J Med Chem; 2022 Aug; 238():114443. PubMed ID: 35635945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiviral effect of aqueous extracts from species of the Lamiaceae family against Herpes simplex virus type 1 and type 2 in vitro.
    Nolkemper S; Reichling J; Stintzing FC; Carle R; Schnitzler P
    Planta Med; 2006 Dec; 72(15):1378-82. PubMed ID: 17091431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo.
    Hou J; Zhang Z; Huang Q; Yan J; Zhang X; Yu X; Tan G; Zheng C; Xu F; He S
    BMC Infect Dis; 2017 Mar; 17(1):217. PubMed ID: 28320320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lupeol impairs herpes simplex virus type 1 replication by inhibiting the promoter activity of the viral immediate early gene α0.
    Ye J; Wang Z; Jia J; Li F; Wang Y; Jiang Y; Wang Y; Ren Z; Pu H
    Acta Virol; 2021; 65(3):254-263. PubMed ID: 34565153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicase primase inhibitors (HPIs) are efficacious for therapy of human herpes simplex virus (HSV) disease in an infection mouse model.
    Uhlig N; Donner AK; Gege C; Lange F; Kleymann G; Grunwald T
    Antiviral Res; 2021 Nov; 195():105190. PubMed ID: 34666109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thiazole Compounds as Antiviral Agents: An Update.
    Singh IP; Gupta S; Kumar S
    Med Chem; 2020; 16(1):4-23. PubMed ID: 31203807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Steps in Herpes Simplex Virus Infection Blocked by a Proteasome Inhibitor.
    Schneider SM; Pritchard SM; Wudiri GA; Trammell CE; Nicola AV
    mBio; 2019 May; 10(3):. PubMed ID: 31088925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of pritelivir and acyclovir in the treatment of herpes simplex virus infections in a mouse model of herpes simplex encephalitis.
    Quenelle DC; Birkmann A; Goldner T; Pfaff T; Zimmermann H; Bonsmann S; Collins DJ; Rice TL; Prichard MN
    Antiviral Res; 2018 Jan; 149():1-6. PubMed ID: 29113740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Complex of the herpes simplex virus initiator protein UL9 with DNA as a platform for the design of a new type of antiviral drugs].
    Surovaia AN; Gorohovskiĭ SL; Gurskiĭ IaG; Andronova VL; Arkhipova VS; Bazhulina NP; Galegov GA; Gurskiĭ GV
    Biofizika; 2010; 55(2):239-51. PubMed ID: 20429277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.